A2 share price frenzy – but is the US formula market worth it?

A2 share price frenzy – but is the US formula market worth it?
The American dream may not be worth it for A2. (Image: Getty)
Jenny Ruth
Some investors believe accessing the US infant formula market would be a big deal for Fonterra and the A2 Milk Company, and trading in A2’s shares last week highlighted that fact.An Australian Financial Review (AFR) journalist got a little over her skis on Tuesday and published a story saying A2 could get US Food & Drug Administration (FDA) approval “as soon as this week”.Both Fonterra and A2 have been waiting for this approval since they applied in late May after the FDA made public it was looking to facilitate infant for...

More Primary Sector

Pāmu backing Alliance Group’s capital raise
Primary Sector

Pāmu backing Alliance Group’s capital raise

The state-owned farmer is one of Alliance's largest shareholders.

Fonterra takes the wheel in Parmesan translation case
Primary Sector

Fonterra takes the wheel in Parmesan translation case

The Singaporean Court of Appeal handed down its ruling last week.

Pāmu lifts guidance as milk price, production rises
Primary Sector

Pāmu lifts guidance as milk price, production rises

State-owned farm operator now expects profit of between $25m and $40m.

Riley Kennedy 22 Nov 2024